-+ 0.00%
-+ 0.00%
-+ 0.00%

PERSPECTIVE THERAPEUTICS, - CO SPONSORS STUDY; MERCK PROVIDES PEMBROLIZUMAB AT NO COST

Reuters·09/14/2026 10:16:00

Please log in to view news